Awarded 1st place in Boehringer Ingelheim Innovation Prize

RegCell’s novel epigenetic reprogramming platform for creating stable/functional antigen-specific Tregs from effector T-cells wins 5th annual Boehringer Ingelheim Innovation Prize in Japan.

Please see the detail (in Japanese only).